CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251
- 26 March 2022
- journal article
- research article
- Published by Springer Nature in Virus Genes
- Vol. 58 (3) , 188-202
Abstract
Chikungunya virus (CHIKV), a (re)emerging arbovirus, is the causative agent of chikungunya fever. To date, no approved vaccine or specific antiviral therapy are available. CHIKV has repeatedly been responsible for serious economic and public health impacts in countries where CHIKV epidemics occurred. Antiviral tests in vitro are generally performed in Vero-B4 cells, a well characterised cell line derived from the kidney of an African green monkey. In this work we characterised a CHIKV patient isolate from Brazil (CHIKVBrazil) with regard to cell affinity, infectivity, propagation and cell damage and compared it with a high-passage lab strain (CHIKVRoss). Infecting various cell lines (Vero-B4, A549, Huh-7, DBTRG, U251, and U138) with both virus strains, we found distinct differences between the two viruses. CHIKVBrazil does not cause cytopathic effects (CPE) in the human hepatocarcinoma cell line Huh-7. Neither CHIKVBrazil nor CHIKVRoss caused CPE on A549 human lung epithelial cells. The human astrocyte derived glioblastoma cell lines U138 and U251 were found to be effective models for lytic infection with both virus strains and we discuss their predictive potential for neurogenic CHIKV disease. We also detected significant differences in antiviral efficacies regarding the two CHIKV strains. Generally, the antivirals ribavirin, hydroxychloroquine (HCQ) and T-1105 seem to work better against CHIKVBrazil in glioblastoma cells than in Vero-B4. Finally, full genome analyses of the CHIKV isolates were done in order to determine their lineage and possibly explain differences in tissue range and antiviral compound efficacies.Keywords
Funding Information
- Bundeswehr Medical Service’s Biodefence research programme
- Deutsches Zentrum für Infektionsforschung (TI 07.003 MD Programme-Hucke)
- Zoonoses Sequencing Network BMBF-ZooSeq (01KI1905A)
This publication has 69 references indexed in Scilit:
- A Specific Domain of the Chikungunya Virus E2 Protein Regulates Particle Formation in Human Cells: Implications for Alphavirus Vaccine DesignJournal of Virology, 2012
- Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 Is Determined by Two Amino Acid Substitutions in the E2 Envelope GlycoproteinJournal of Virology, 2012
- Arbovirus high fidelity variant loses fitness in mosquitoes and miceProceedings of the National Academy of Sciences, 2011
- Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reactionVirology Journal, 2011
- Genome-Scale Phylogenetic Analyses of Chikungunya Virus Reveal Independent Emergences of Recent Epidemics and Various Evolutionary RatesJournal of Virology, 2010
- Replication cycle of chikungunya: A re-emerging arbovirusVirology, 2009
- Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug ResistanceJournal of Virology, 2009
- Growth and Maintenance of Vero Cell LinesCurrent Protocols in Microbiology, 2008
- Connective tissue metabolism in chikungunya patientsVirology Journal, 2008
- Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA cloneVirology, 1991